Dajun Yang

Chairman and CEO at Ascentage Pharma Group International

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
7 months
Director since
2026

7 months of board service in total across 1 board, counting each seat separately. Longest: Ascentage Pharma Group International, 7 months.

Ascentage Pharma Group International Director · Chairman and CEO
7 months · Since 2026

Chief executive roles

Since March 2026

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
May 21, 2026 Ascentage Pharma Group International Option exercise +95,575 — —
May 21, 2026 Ascentage Pharma Group International Option exercise +92,746 — —

Questions about Dajun Yang

What boards is Dajun Yang on?

Dajun Yang sits on the board of Ascentage Pharma Group International.

What company is Dajun Yang the CEO of?

Dajun Yang has been Chairman and CEO of Ascentage Pharma Group International since March 2026.

How long has Dajun Yang served on boards?

Our records show at least 7 months of board service across 1 board, the earliest from 2026.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.